Delivery Order SPE2DR25D3012-SPE2DR26F4E1E
Award Date 12/29/25
Potential Completion Date 1/21/26
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Ibrance 125 mg capsules (21-count units) with a contract ceiling value of $8,555.21. This is a firm fixed-price delivery order with an ultimate completion date of January 2, 2026, representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively made with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Ibrance 125 mg capsules (21-count packaging) with a firm fixed price ceiling value of $8,555.21 and an ultimate completion date of December 12, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ibrance 125 mg capsules (21-count packages) valued at $8,555.21 with a firm fixed price structure. The contract is classified as a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a $8,555.21 delivery order to AmerisourceBergen Drug Corp for Ibrance 125 mg capsules (quantity 21) on December 20, 2025, with completion targeted for January 13, 2026. This is a firm fixed-price, non-competitive set-aside delivery order issued to the prime contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a $8,559.84 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Ibrance 100 mg capsules (21-count). This competitive, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of January 8, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract issued under AmerisourceBergen's larger Indefinite...
- This delivery order, valued at $8,559.84 and awarded December 29, 2025, provides Ibrance 100 mg capsules (21-count packaging) to the Defense Logistics Agency (DLA) through a firm fixed-price arrangement. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, with performance centered at the company's Conshohocken, Pennsylvania headquarters. This is an uncompetitive set-aside contract awarded as a child order...
- The Defense Logistics Agency awarded a delivery order valued at $34,220.84 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg capsules (21-count) on December 3, 2025, with an ultimate completion date of December 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite...
- The Defense Logistics Agency awarded a $8,555.21 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ibrance 125 mg capsules (21-count packages). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of December 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $17,122.82 to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg capsules (21-count units) on November 25, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg capsules (quantity 21) under a firm fixed-price contract valued at $8,555.21. The delivery order, issued on October 23, 2025, carries an ultimate completion date of November 14, 2025. This non-set-aside award represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and will be performed at the company's corporate office location...